ABOUT

new top timeline_2010-2017.png
 

A PIONEERING COMPANY OF FIRSTS

 

 

 

 

 

 

 

 

 

 
 
 
 
 
 
 
 
 
 
2018-01.png
 

APRIL 2018
HIGH PARK COMPANY LAUNCHES

Tilray launches High Park Company, a wholly-owned subsidiary to capture Canada’s adult-use cannabis market. Based in Toronto and led by a team with deep experience in cannabis and global consumer brands, High Park has secured the exclusive rights to produce and distribute a broad-based portfolio of adult-use cannabis brands and products in Canada. The company also announced that it is making an investment of up to $10 million in a new facility located in London, Ontario to process and distribute finished cannabis products.

HPC Logo White.png
 
 
2018-01.png
 

MARCH 2018
TILRAY SIGNS SUPPLIER AGREEMENT WITH PHARMASAVE

Tilray announces that it has entered into an agreement to become a preferred medical cannabis supplier to Pharmasave, the premier independent pharmacy banner in Canada.

 
 
2018-01.png
 

MARCH 2018
TILRAY FORMS ALLIANCE WITH SANDOZ

Tilray becomes the world’s first federally licensed medical cannabis producer to form a strategic alliance with a local affiliate of a global pharmaceutical company with a binding letter of intent (LOI) to be the exclusive collaborator of Sandoz Canada, part of the Novartis Group.

 
 
2018-01.png
 

FEBRUARY 2018
TILRAY ANNOUNCES PROVINCIAL SUPPLY AGREEMENTS

Tilray announces agreements with Société des alcools du Québec (SAQ) and National Access Cannabis (NAC) to supply the adult-use cannabis market in Quebec and Manitoba.

 
 
2018-01.png
 

FEBRUARY 2018
TILRAY EXPORTS TO SOUTH AFRICA

Africa becomes the fifth continent where Tilray products are available.

 
 
2018-01.png
 

FEBRUARY 2018
TILRAY CLOSES SERIES A

Tilray announces the completion of a C$60 million Series A funding round led by global institutional investors. The round marks the first time that outside investors have invested directly into a Privateer Holdings portfolio company. With its Series A funding and incorporation, Tilray is positioned to operate and finance its growth independent of Privateer Holdings.

 
 
2018-01.png
 

JANUARY 2018
TILRAY SIGNS SUPPLIER AGREEMENT WITH SHOPPERS DRUG MART

Tilray announces that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart, one of Canada’s largest pharmacy chains.

 
 
2018-01.png
 

JANUARY 2018
PRIVATEER CLOSES SERIES C, ANNOUNCES EQUITY PLEDGE

Privateer Holdings closes its Series C funding round. The more than $100 million in new funding brings the firm’s fundraising total to $200 million, the largest private capital raise closed in the legal cannabis industry to date. In addition to announcing the close of the round, Privateer Holdings founders Brendan Kennedy, Michael Blue and Christian Groh pledge to donate shares of their personal holdings in the firm to support communities that have been harmed by cannabis prohibition worldwide. Currently equivalent to $5 million, the value of the equity pledged will grow over time with the value of the firm.

 
 
2017-01.png
 

DECEMBER 2017

TILRAY EXPORTS TO THE CZECH REPUBLIC

The Czech Republic becomes the fourth EU country with Tilray products available to patients.

 
 
2017-01.png
 

DECEMBER 2017
PRIVATEER HOLDINGS AQUIRES THE GOODSHIP

The Goodship, one of Washington state’s leading edibles brands, joins the Privateer Holdings portfolio. Together, The Goodship and Privateer Holdings plan to develop new products and expand the brand’s availability to consumers in new markets across North America.

2017-12 Goodship.jpg
 
 
2017-01.png
 

DECEMBER 2017
LEAFLY PUBLISHES FIRST BOOK

“A weirdly fascinating volume … [on] a new kind of cultivated landscape that may soon stretch from sea to shining sea.” —The New York Times Book Review

Find The Leafly Guide to Cannabis online or at a bookseller near you.

2017-12 Leafly.jpg
 
 
2017-01.png
 

NOVEMBER 2017
TILRAY EXPORTS GENETICS TO PORTUGAL

Tilray successfully exports live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal. The announcement is the first time a company has legally exported live cannabis genetics from North America to Europe and marks another strategic milestone as Tilray develops its EU Campus into the region’s leading medical cannabis research and production facility.

 
 
2017-01.png
 

OCTOBER 2017
TILRAY EXPORTS TO GERMANY

Tilray becomes the first Canadian licensed producer to legally import full-spectrum medical cannabis extract products into Germany for nationwide distribution through pharmacies. To distribute its products nationwide, Tilray has partnered with pharmaceutical wholesaler NOWEDA and service provider Paesel + Lorei. With more than €6 billion in annual revenue, NOWEDA is one of the largest pharmaceutical wholesalers in Germany.

2017-10.jpg
 
 
2017-01.png
 

SEPTEMBER 2017
TILRAY ANNOUNCES EU CAMPUS

Tilray receives a license to produce medical cannabis in the European Union, becoming the first licensed producer with federal cultivation licenses from two countries. The company will invest up to €20 million in a European Union Campus in Cantanhede, Portugal.

2017-09.jpg
 
 
2017-01.png
 

AUGUST 2017
TILRAY ANNOUNCES SECOND FACILITY

Tilray Announces Second Facility

 
 
2017-01.png
 

JULY 2017
MARLEY NATURAL'S EUROPEAN DEBUT AT COLETTE

Marley Natural at Colette

 
 
2017-01.png
 

MAY 2017
TILRAY MEDICAL ADVISORY BOARD

Tilray Medical Advisory Board

 
 
2017-01.png
 

APRIL 2017
MARLEY NATURAL EXPANDS TO WASHINGTON

Marley Natural Expands to Washington

 
 
2017-01.png
 

FEBRUARY 2017
TILRAY EXPANDS TO FOURTH CONTINENT

Tilray enters Latin America with exports to Chile. The company now serves patients on
four continents. 

 
 
 

DECEMBER 2016
TILRAY RECEIVES GMP CERTIFICATION

Tilray becomes North America’s first GMP certified medical cannabis producer

 
 
 

NOVEMBER 2016
TILRAY ANNOUNCES PEDIATRIC EPILEPSY
CLINICAL TRIAL

Tilray announces its support for a clinical trial at The Hospital for Sick Children in Toronto (SickKids) to study medical cannabis extracts and treatment-resistant epilepsy in children. The trial, which uses preparations developed by Tilray, receives coverage from The Canadian Press

 
 
 

NOVEMBER 2016
LEAFLY SURPASSES 10 MILLION UNIQUE VISITORS PER MONTH

Monthly traffic exceeds that of many popular non-cannabis websites, including
The Atlantic, Financial Times, and New York Magazine.

 
 
 

OCTOBER 2016
PRIVATEER HOLDINGS CLOSES $40M IN CONVERTIBLE BRIDGE FINANCING

The $40 million in new funding brings Privateer’s fundraising total to $122 million, marking the first time a cannabis company has raised more than $100 million.
The news appears in ReutersFortune, and other major financial publications.

 
 
 

SEPTEMBER 2016
TILRAY BEGINS PATIENT RECRUITMENT FOR
PTSD TRIAL

The clinical trial, which uses a Tilray study drug, is the largest medical cannabis clinical trial to take place in Canada in the last 40 years. The Vancouver Sun covers
the milestone. 

 
 
 

SEPTEMBER 2016
TILRAY EXPANDS TO THIRD CONTINENT

Tilray begins exporting to Australia for compassionate access and clinical
research purposes. 

 
 
 

SEPTEMBER 2016
LEAFLY NEWS RE-LAUNCHES

Leafly hires a team of world-class journalists and debuts a redesigned editorial website to better showcase its world-class cannabis content. 

 
 
 

AUGUST 2016
LEAFLY'S FIRST EUROPEAN EVENT

Leafly celebrates the global cannabis movement at the 20th anniversary of Hanfparade, Germany’s largest pro-cannabis event. 

 
 
 
 
 

AUGUST 2016
MARLEY NATURAL RISE UP EXPUNGEMENT DAY

Marley Natural partners with the Minority Cannabis Business Association to host Rise Up Expungement Day. Dozens of people with criminal records for non-violent cannabis-related offenses have the opportunity to file official expungement requests with the State of Oregon. USA TODAY covers the news. 

 
 
 

AUGUST 2016
LEAFLY NAMED ONE OF AMERICA'S FASTEST
GROWING COMPANIES

Inc. ranks Leafly #76 on its 35th annual Inc. 5000, the most prestigious ranking of the nation's fastest-growing private businesses.

 
 
 

JUNE 2016
TILRAY BEGINS EXPORTING CANNABIS INTERNATIONALLY

In June, Tilray made history when it became the first company to legally ship medical cannabis products from North America to the European Union. Tilray's liquid cannabis capsules are now being distributed in pharmacies across Croatia. Read more about this historic milestone in CBC News.

 
 
 
 

FEBRUARY 2016
ANNOUNCED AUSTRALIAN CLINICAL RESEARCH PARTNERSHIP

Tilray partners with the University of Sydney, New South Wales Government, and Chris O'Brien Lifehouse (one of Australia's leading cancer hospitals) to conduct a first-of-its-kind clinical trial studying how cannabinoids can benefit patients with chemotherapy-induced nausea and vomiting (CINV).

 

 
 

FEBRUARY 2016
LAUNCHED MARLEY NATURAL

Marley Natural debuts premium cannabis products, a body care line, and smoking accessories.

 
 

JANUARY 2016
LEAFLY COMEDY TOUR LAUNCHES

The Leafly Comedy Tour hosts its first show in Seattle. The yearlong tour becomes a smash-hit in 11 cities across North America: Los Angeles, Denver, Chicago, Toronto, San Francisco, Portland, Phoenix, Brooklyn, Boston, Austin, and Vancouver.

 
 

OCTOBER 2015
TILRAY LAUNCHES EXTRACTS PRODUCT LINE

Tilray debuts a broad-based line of medical cannabis extract products in Canada.

Tilray_Drops.png
 
 
 

MARCH 2015
HIRED CATHERINE JACOBSON, DIRECTOR OF CLINICAL RESEARCH

Dr. Catherine Jacobson is responsible for creating and managing clinical research partnerships for Privateer Holdings.

 
 

MARCH 2015
$75 MILLION SERIES B ROUND CLOSES

Privateer Holdings announces the largest funding round ever closed by a private equity firm in the cannabis industry - $75 million.

 
 

DECEMBER 2014
FOUNDERS FUND BECOMES FIRST INSTITUTIONAL INVESTOR IN LEGAL CANNABIS

Peter Thiel’s Founders Fund becomes the first institutional investor in the legal cannabis industry through an investment in Privateer Holdings’ Series B round. The news is announced on CBS This Morning and generates more than 2 billion impressions.

 

 

NOVEMBER 2014
MARLEY NATURAL DEBUTS ON NBC’s TODAY SHOW

Marley Natural – a partnership between Privateer Holdings and the family of Bob Marley – is unveiled as the world’s first global cannabis brand, on NBC’s Today Show. The news is heard around the world, resulting in more than 2 billion earned media impressions and more than 2,000 stories printed in 196 countries.

 
 

AUGUST 2014
LEAFLY PUBLISHES FIRST CANNABIS AD IN THE NEW YORK TIMES

Leafly becomes the first cannabis company to place a full-page print advertisement in The New York Times, congratulating the state of New York on passing the Compassionate Care Act and reminding consumers to #JustSayKnow.

 
 

MAY 2014
LEAFLY IS NAMED APP OF THE YEAR